Related Experiment Video
Updated: May 22, 2026
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Neonatal Kasabach-Merritt phenomenon
Dinesh Yadav1, Anu Maheshwari, Satinder Aneja
1Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital, New Delhi, India.
Summary
Kasabach-Merritt phenomenon (KMP) is a rare, life-threatening coagulopathy. This case highlights successful treatment of KMP in a neonate with facial hemangioma using steroids and vincristine.
Area of Science:
- Pediatric Hematology
- Neonatal Medicine
- Vascular Anomalies
Background:
- Kasabach-Merritt phenomenon (KMP) is a rare, life-threatening consumptive coagulopathy associated with rapidly enlarging vascular tumors.
- While typically presenting in early infancy, KMP onset in the neonatal period, particularly with facial hemangiomas, is exceptionally uncommon.
